Skip to content

Analysis of the Results of Treatment for Cervical Carcinoma in Limburg

Retrospective Analysis of Treatment and Quality of Life of Women Treated for Cervical Carcinoma FIGO Stage IB-1 to IVb From 2000-2008 in Limburg, a Province in the South of the Netherlands.

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01059695
Acronym
CervixLimburg
Enrollment
220
Registered
2010-02-01
Start date
2010-02-28
Completion date
2011-07-31
Last updated
2015-01-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cervical Cancer

Keywords

cervical cancer, retrospective, quality of life, treatment

Brief summary

Analysis of all women treated for cervical cancer between 2000 and 2008 in Limburg, a province in the south of the Netherlands. Patient characteristics, diagnosis, treatment modalities, complications and survival will be analyzed by record review. Quality of life of the living study population will be assessed using the EORTC QLQ-C30 and QOQ-CX24 questionnaire. Patients will be identified via registration data from the Integraal Kankercentrum Limburg.

Interventions

None listed

Sponsors

Maastricht University Medical Center
CollaboratorOTHER
Atrium Medical Center
CollaboratorOTHER
Maastricht Radiation Oncology
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Healthy volunteers
No

Inclusion criteria

* cervical cancer FIGO stage IB-1 to IVB * Treated in Limburg between 2000 and 2008

Exclusion criteria

* none

Design outcomes

Primary

MeasureTime frameDescription
Quality of lifeQuality of life of the living study population will be assessed using the EORTC QLQ-C30 and QOQ-CX24 questionnaire

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026